Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...
Amazon S3 on MSN
FDA approves first gene therapy for hearing loss in the US
The US Food and Drug Administration has approved the first-ever gene therapy specifically targeting genetic hearing loss—a ...
The US Food and Drug Administration has granted approval for the inaugural gene therapy aimed at addressing genetic hearing ...
The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. The drugmaker said it will offer the drug for free to U.S. patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results